FDA Approves First Treatment for a Rare Lipid Storage Disease
On February 21, 2025, the Food and Drug Administration of the United States (FDA) approved Ctexli (chenodiol) for CTX therapy ...
FDA Approves Tenecteplase for Acute Ischemic Stroke (AIS)
Recently, the U.S. Food and Drug Administration (FDA) approved TNKase (tenecteplase) for the use of treating adults with acute ischemic ...
First Generic GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA
On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) ...
WHO Approves World’s First Diagnostic Test for MPox
The World Health Organization (WHO) has taken a critical step in improving global access to MPox testing by listing the ...
FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC)
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved Miplyffa (arimoclomol), a groundbreaking treatment for Niemann-Pick disease, ...
MPOX Virus Truths: Is It a Real Public Health Threat or a Hoax?
The World Health Organization (WHO) has labeled the multi-country outbreak of Mpox a public health emergency, raising concerns worldwide. Given ...
Underground Demand: India’s Rich Seek Elusive Weight-Loss Drugs
As global demand for weight-loss drugs like Ozempic and Mounjaro surges, affluent Indians are going to great lengths to secure ...
FDA Approves New Treatment Option for HER2-Positive Cancers
The United States Food and Drug Administration (FDA) has approved a new medicine called trastuzumab-strf (HLX02, brand name Hercessi). This ...
FDA Approves Pivya (pivmecillinam)Tablets for Uncomplicated Urinary Tract Infections
In a recent landmark decision, the U.S. Food and Drug Administration (FDA) has granted approval to Pivya (pivmecillinam) tablets for ...